Vertex Pharmaceuticals names new chief medical officer
7 March 2018 -

Vertex Pharmaceuticals, a biotech known for its clinical development programmes in cystic fibrosis, has named Reshma Kewalramani as its new chief medical officer, it was reported yesterday.

Kewalramani succeeds Jeffrey Chodakewitz, who will remain at the company as a senior advisor until early 2019.

Prior to joining the biotech, Kewalramani served as vice president, head of the US medical organisation at Amgen, where she spent 12 years in various capacities.